Ophthalmic dynamic aperture
Details for Australian Patent Application No. 2008218240 (hide)
International Classifications
Event Publications
17 September 2009 PCT application entered the National Phase
PCT publication WO2008/103906 Priority application(s): WO2008/103906
8 December 2011 Amendment Made
The nature of the amendment is: Amend the priority details to read 61/025,348 01 Feb 2008 US; 61/020,759 14 Jan 2008 US and 60/902,866 23 Feb 2007 US 2008246195 Chimerix, Inc. The nature of the amendment is: Amend the invention title to read Methods of Reducing Nephrotoxicity in Subjects Administered with Nucleoside Phosphonates
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser